Alan B. Lancz & Associates, Inc. Haleon PLC Transaction History

Alan B. Lancz & Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$7.78 - $8.62 $3,112 - $3,447	-400 Reduced 2.96%	13,125 $108,000
Q3 2023 Nov 13, 2023	SELL	$7.85 - $8.94 $2,355 - $2,682	-300 Reduced 2.17%	13,525 $112,000
Q2 2023 Aug 09, 2023	BUY	$8.04 - $9.0 $111,152 - $124,425	13,825 New	13,825 $115,000

638

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $43.4B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Alan B. Lancz & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Alan B. Lancz & Associates, Inc. with notifications on news.